title: Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins.
abstract: Regulator of G-protein signaling (RGS) proteins are strong modulators of G-protein-mediated pathways in the nervous system. One function of RGS proteins is to accelerate the activation-deactivation kinetics of G-protein-coupled inwardly rectifying potassium (GIRK) channels. The opening of GIRK channels reduces the firing rates of neurons. Recent studies indicate that RGS proteins also modulate the coupling efficiency between gamma-aminobutyric acid type B (GABA(B)) receptors and GIRK channels in dopamine neurons of the ventral tegmental area (VTA), the initial target for addictive drugs in the brain reward pathway. Chronic drug exposure can dynamically regulate the expression levels of RGS. Functional and behavioral studies now reveal that levels of RGS2 protein, through selective association with GIRK3, critically determine whether GABA(B) agonists are excitatory or inhibitory in the VTA. The regulation of RGS protein in the reward pathway might underlie adaptation to different types of addictive drugs.
authors.affiliation: Department of Basic Neurosciences, Medical Faculty, University of Geneva, 1, Michel-Servet, CH-1211 Geneva, Switzerland.
authors.forename: Marta
authors.initials: M
authors.lastname: Lomazzi
authors.forename: Paul A
authors.initials: PA
authors.lastname: Slesinger
authors.forename: Christian
authors.initials: C
authors.lastname: Lüscher
mesh_terms: D000818:Animals; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels / Q000235:genetics* / Q000502:physiology*; D020555:GTP-Binding Protein Regulators / Q000235:genetics* / Q000502:physiology*; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects* / Q000235:genetics*; D019966:Substance-Related Disorders / Q000235:genetics*
chemical_list: D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D020555:GTP-Binding Protein Regulators
references.citation: J Neurosci. 1998 Sep 15;18(18):7178-88
references.pmid: 9736641
references.citation: Neuropsychopharmacology. 2005 Jan;30(1):99-110
references.pmid: 15199376
references.citation: J Biol Chem. 2000 Nov 17;275(46):36211-6
references.pmid: 10956667
references.citation: J Pharmacol Exp Ther. 2001 Jun;297(3):837-45
references.pmid: 11356902
references.citation: Semin Cell Dev Biol. 2006 Jun;17(3):363-76
references.pmid: 16687250
references.citation: Mol Cell Biol. 1996 Sep;16(9):5194-209
references.pmid: 8756677
references.citation: Rev Physiol Biochem Pharmacol. 2002;145:47-179
references.pmid: 12224528
references.citation: Mol Interv. 2005 Feb;5(1):30-41
references.pmid: 15734717
references.citation: J Neurochem. 1999 Apr;72(4):1529-33
references.pmid: 10098858
references.citation: Cell. 1996 Jan 12;84(1):115-25
references.pmid: 8548815
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S379-88
references.pmid: 18059321
references.citation: Pharmacol Rev. 2002 Sep;54(3):527-59
references.pmid: 12223533
references.citation: Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50
references.pmid: 12209124
references.citation: J Biol Chem. 1999 Apr 2;274(14):9899-904
references.pmid: 10092682
references.citation: Neuropsychopharmacology. 2005 Aug;30(8):1443-54
references.pmid: 15770241
references.citation: Science. 2004 Dec 10;306(5703):1944-7
references.pmid: 15591205
references.citation: J Neurochem. 2003 Mar;84(5):1118-27
references.pmid: 12603835
references.citation: J Recept Signal Transduct Res. 2008;28(1-2):83-91
references.pmid: 18437632
references.citation: Methods Enzymol. 2004;389:131-54
references.pmid: 15313564
references.citation: Eur J Biochem. 2000 Oct;267(19):5830-6
references.pmid: 10998041
references.citation: J Biol Chem. 2006 Nov 10;281(45):34549-60
references.pmid: 16973624
references.citation: Neuron. 2003 Jun 19;38(6):941-52
references.pmid: 12818179
references.citation: Annu Rev Biochem. 2004;73:925-51
references.pmid: 15189163
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13656-61
references.pmid: 14595021
references.citation: Annu Rev Pharmacol Toxicol. 2008;48:537-68
references.pmid: 18184106
references.citation: J Neurochem. 2006 Mar;96(6):1606-15
references.pmid: 16539683
references.citation: Neurobiol Dis. 2002 Aug;10(3):334-43
references.pmid: 12270694
references.citation: Eur J Neurosci. 2003 Mar;17(5):971-80
references.pmid: 12653973
references.citation: Biochem Biophys Res Commun. 1998 Feb 4;243(1):52-5
references.pmid: 9473478
references.citation: J Biol Chem. 1996 Apr 5;271(14):7999-8007
references.pmid: 8626481
references.citation: PLoS Med. 2006 Nov;3(11):e437
references.pmid: 17105338
references.citation: J Neurosci. 2007 Jun 13;27(24):6388-99
references.pmid: 17567799
references.citation: Annu Rev Psychol. 2006;57:87-115
references.pmid: 16318590
references.citation: Nat Neurosci. 2006 Jan;9(1):31-40
references.pmid: 16311589
references.citation: Neuron. 2002 Jan 3;33(1):87-99
references.pmid: 11779482
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11727-32
references.pmid: 9751733
references.citation: Nat Neurosci. 2004 Feb;7(2):153-9
references.pmid: 14745451
references.citation: J Cell Biochem. 2002;85(4):837-50
references.pmid: 11968023
references.citation: J Physiol. 2007 Apr 1;580(Pt 1):51-65
references.pmid: 17185339
references.citation: Neuropharmacology. 2005 Sep;49(4):465-76
references.pmid: 15935408
references.citation: Trends Neurosci. 2005 Aug;28(8):436-45
references.pmid: 15982754
references.citation: Nat Neurosci. 2007 Dec;10(12):1559-68
references.pmid: 17965710
references.citation: J Neurosci. 2006 Mar 1;26(9):2522-30
references.pmid: 16510730
references.citation: J Physiol. 1999 Jun 1;517 ( Pt 2):341-52
references.pmid: 10332086
references.citation: J Mol Biol. 2007 Feb 16;366(2):349-65
references.pmid: 17173929
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10461-6
references.pmid: 9294233
references.citation: Annu Rev Biochem. 2000;69:795-827
references.pmid: 10966476